Surmodics SRDX
$ 39.15
-0.1%
Annual report 2024
added 11-20-2024
Country |
USA |
IPO year |
1998 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Gary Maharaj |
Employees in the company |
370 |
Shares |
14.2 M |
Market Cap[1] |
$ 549 M |
EBITDA (LTM) |
$ 25.1 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.